VCU Health System opens $384M adult outpatient pavilion

GLP-1 drugs linked to improved breast cancer survival, VCU Massey-led study finds

A research team led by investigators at Virginia Commonwealth University found evidence suggesting there is a positive association between GLP-1 agonists—drugs commonly used to treat obesity and diabetes—and better outcomes among breast cancer patients.

May 15, 2026

Vol.52 No.19

In Brief

VCU Massey–Sanford Burnham Prebys Drug Discovery Collaborative Program launches two projects

The VCU Massey Comprehensive Cancer Center completed the inaugural funding cycle of its VCU–Sanford Burnham Prebys Drug Discovery Collaborative Program, a collaboration with the Sanford Burnham Prebys Medical Discovery Institute in La Jolla, CA.

April 10, 2026

Vol.52 No.14

Clinical Roundup

Small molecule inhibitor blocks prostate cancer bone metastasis

Findings out of VCU Massey Comprehensive Cancer Center and the VCU Institute of Molecular Medicine, published in Pharmacological Research, show that a targeted small molecule inhibitor, IVMT-Rx-4, may prevent prostate tumors from spreading to an advanced and incurable stage in the bones.

April 03, 2026

Vol.52 No.13

In Brief

Lisa Roth named director of pediatric hematology-oncology at Hassenfeld Children’s Hospital at NYU Langone

Lisa G. Roth was named director of the Division of Pediatric Hematology-Oncology at Hassenfeld Children’s Hospital at NYU Langone and Perlmutter Cancer Center. Roth is a pediatric oncologist, physician-scientist, and lymphoma survivor.

March 27, 2026

Vol.52 No.12

Clinical Roundup

VCU Massey researchers lead international effort to produce multi-omic digital atlas of oral tissues

Researchers at VCU Massey Comprehensive Cancer Center led an international effort to create a multi-omic atlas of oral tissues with the aim of advancing the understanding of the immunoregulatory nature of human oral tissues. Recent analyses using data from this atlas suggest that fibroblasts may serve as the core regulators of structural immunity in the mouth.

March 27, 2026

Vol.52 No.12

Clinical Roundup

Researchers at VCU identify Achilles’ heel in lung cancer through common genetic mutation

A team of researchers at VCU Massey Comprehensive Cancer Center has identified a new pathway through which mutations in the tumor suppressor p53 gene—found very frequently in human tumors—hijack DNA replication in cancer cells.

March 13, 2026

Vol.52 No.10

VCU Health System opens $384M adult outpatient pavilion

YOU MAY BE INTERESTED IN

GLP-1 drugs linked to improved breast cancer survival, VCU Massey-led study finds

VCU Massey–Sanford Burnham Prebys Drug Discovery Collaborative Program launches two projects

Small molecule inhibitor blocks prostate cancer bone metastasis

Lisa Roth named director of pediatric hematology-oncology at Hassenfeld Children’s Hospital at NYU Langone

VCU Massey researchers lead international effort to produce multi-omic digital atlas of oral tissues

Researchers at VCU identify Achilles’ heel in lung cancer through common genetic mutation

Renew today!

Subscriber content

Never miss an issue!

Login